 |
163 Diseases |  |
2 Trials |
|
2 Trials |  |
155 News |  |
| «12 |
- bryostatin 1 (NSC 339555) / Synaptogenix
Enrollment change, Trial termination: Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease (clinicaltrials.gov) - Apr 25, 2015
P1/2, N=9, Terminated, Sponsor: Neurotrope Bioscience, Inc.
N=15 --> 9 | Recruiting --> Terminated; Part 2 of study replaced by NTRP-101-202, assessing 3 doses of bryostatin.
- bryostatin 1 (NSC 339555) / Synaptogenix
New P1/2 trial: Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease (clinicaltrials.gov) - Aug 21, 2014
P1/2, N=15, Recruiting, Sponsor: Neurotrope Bioscience, Inc.